Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: An Analysis of the Literature on Efficacy, Morbidity, and Mortality
Cause of Death
Portasystemic Shunt, Transjugular Intrahepatic
TIPS is effective in eliminating ascites or substantially reducing ascites in cases refractory to medical therapy. Renal insufficiency, refractory encephalopathy, and hyperbilirubinemia were consistently associated with mortality after TIPS. In individuals with risk factors for mortality, alternative strategies should be recommended.